Liposomes and liposome-like vesicles for drug and DNA delivery to mitochondria.
Mitochondrial research is presently one of the fastest growing disciplines in biomedicine. Since the early 1990s, it has become increasingly evident that mitochondrial dysfunction contributes to a large variety of human disorders, ranging from neurodegenerative and neuromuscular diseases, obesity, and diabetes to ischemia-reperfusion injury and cancer. Most remarkably, mitochondria, the "power house" of the cell, have also become accepted as the "motor of cell death" reflecting their recognized key role during apoptosis. Based on these recent exciting developments in mitochondrial research, increasing pharmacological efforts have been made leading to the emergence of "Mitochondrial Medicine" as a whole new field of biomedical research. The identification of molecular mitochondrial drug targets in combination with the development of methods for selectively delivering biologically active molecules to the site of mitochondria will eventually launch a multitude of new therapies for the treatment of mitochondria-related diseases, which are based either on the selective protection, repair, or eradication of cells. Yet, while tremendous efforts are being undertaken to identify new mitochondrial drugs and drug targets, the development of mitochondria-specific drug carrier systems is lagging behind. To ensure a high efficiency of current and future mitochondrial therapeutics, colloidal vectors, i.e., delivery systems, need to be developed able to selectively transport biologically active molecules to and into mitochondria within living human cells. Here we review ongoing efforts in our laboratory directed toward the development of different phospholipid- and non-phospholipid-based mitochondriotropic drug carrier systems.
Weissig
Volkmar
V
Northeastern University, Bouve College of Health Sciences, School of Pharmacy, Department of Pharmaceutics, Boston, MA 02115, USA. v.weissig@neu.edu
Boddapati
Sarathi V
SV
Cheng
Shing-Ming
SM
D'Souza
Gerard G M
GG
D004247:DNA / Q000008:administration & dosage*; D004337:Drug Carriers; D008081:Liposomes; D008928:Mitochondria / Q000378:metabolism*
D004337:Drug Carriers; D008081:Liposomes; D004247:DNA